Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Nanocarrier-based treatments show promise for better hair growth in androgenetic alopecia but need more research.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Finasteride effectively treats BPH and hair loss but may cause sexual side effects.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

Once-daily 5% minoxidil foam increases hair regrowth and density in women with hair loss, but not as effectively as twice-daily 2% minoxidil solution, though it's safer and more convenient.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Monitoring new epilepsy drugs after they're sold is crucial to find rare and long-term side effects that initial tests might miss.

The regenerative medicine industry saw business growth with new partnerships, clinical trials, and financial investments.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

The new gel combining calcipotriene and betamethasone is effective and safe for treating scalp psoriasis.

The drug combination was safe and showed promise in treating advanced tumors.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Minoxidil was first made for high blood pressure, but it was later found to help hair growth.